Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors

Nature Immunology

Volumn 12, Issue 9, 2011, Pages 827-833

  Pellicci, Daniel G ^a   Clarke, Andrew J ^b   Patel, Onisha ^b   Mallevaey, Thierry ^c   Beddoe, Travis ^b   Le Nours, Jérǒme ^b   Uldrich, Adam P ^a   McCluskey, James ^a   Besra, Gurdyal S ^d   Porcelli, Steven A ^e   Gapin, Laurent ^c   Godfrey, Dale I ^a   Rossjohn, Jamie ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSYLCERAMIDE; CD1D ANTIGEN; GALACTOSYLCERAMIDE; ISOGLOBOTRIHEXOSYLCERAMIDE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; CELL STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD1D; AUTOIMMUNITY; BINDING SITES; CRYSTALLOGRAPHY, X-RAY; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; GLOBOSIDES; HUMANS; HYBRIDOMAS; KINETICS; MICE; MODELS, MOLECULAR; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; NATURAL KILLER T-CELLS; PROTEIN BINDING; PROTEIN ENGINEERING; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE; TRIHEXOSYLCERAMIDES;

EID: 80052031099     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2076     Document Type: Article

References (50)

1. Rudolph, M.G., Stanfield, R.L. & Wilson, I.A. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24, 419-466 (2006).
2. Takada, K. & Jameson, S.C. Naive T cell homeostasis: from awareness of space to a sense of place. Nat. Rev. Immunol. 9, 823-832 (2009).
3. Harkiolaki, M. et al. T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 30, 348-357 (2009).
4. Hogquist, K.A., Baldwin, T.A. & Jameson, S.C. Central tolerance: learning self-control in the thymus. Nat. Rev. Immunol. 5, 772-782 (2005). (Pubitemid 41400851)
5. Godfrey, D.I. et al. Antigen recognition by CD1d-restricted NKT T cell receptors. Semin. Immunol. 22, 61-67 (2010).
6. Godfrey, D.I. & Rossjohn, J. New ways to turn on NKT cells. J. Exp. Med. 208, 1121-1125 (2011).
7. Cerundolo, V., Silk, J.D., Masri, S.H. & Salio, M. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9, 28-38 (2009).
8. Godfrey, D.I., MacDonald, H.R., Kronenberg, M., Smyth, M.J. & Van Kaer, L. NKT cells: what's in a name? Nat. Rev. Immunol. 4, 231-237 (2004). (Pubitemid 38339089)
9. Gumperz, J.E. et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211-221 (2000). (Pubitemid 30398635)
10. Kinjo, Y. et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7, 978-986 (2006). (Pubitemid 44263912)
11. Borg, N.A. et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 448, 44-49 (2007). (Pubitemid 47037002)
12. Pellicci, D.G. et al. Differential recognition of CD1d-α-galactosyl ceramide by the Vβ8.2 and Vβ7 semi-invariant NKT T cell receptors. Immunity 31, 47-59 (2009).
13. Wun, K.S. et al. A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells. Immunity 34, 327-339 (2011).
14. Aspeslagh, S. et al. Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis. EMBO J. 30, 2294-2305 (2011).
15. Uldrich, A.P. et al. A semi-invariant V10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties. Nat. Immunol. 12, 616-623 (2011).
16. Li, Y. et al. The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. J. Exp. Med. 207, 2383-2393 (2010).
17. Chiu, Y.H. et al. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d. Nat. Immunol. 3, 55-60 (2002).
18. Brigl, M. & Brenner, M.B. How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens. Semin. Immunol. 22, 79-86 (2010).
19. Ortaldo, J.R. et al. Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides. J. Immunol. 172, 943-953 (2004). (Pubitemid 38113753)
20. Parekh, V.V. et al. Quantitative and qualitative differences in the in vivo response of NKT cells to distinct α-and β-anomeric glycolipids. J. Immunol. 173, 3693-3706 (2004). (Pubitemid 39280730)
21. Matulis, G. et al. Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3β loop. PLoS Biol. 8, e1000402 (2010).
22. Zhou, D. et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789 (2004). (Pubitemid 39601398)
23. Wu, D.Y., Segal, N.H., Sidobre, S., Kronenberg, M. & Chapman, P.B. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198, 173-181 (2003). (Pubitemid 36870197)
24. Koch, M. et al. The crystal structure of human CD1d with and without α-galactosylceramide. Nat. Immunol. 6, 819-826 (2005). (Pubitemid 43090468)
25. Zajonc, D.M. et al. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat. Immunol. 6, 810-818 (2005). (Pubitemid 43090467)
26. Zajonc, D.M. et al. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J. Exp. Med. 202, 1517-1526 (2005). (Pubitemid 41746598)
27. Zajonc, D.M., Savage, P.B., Bendelac, A., Wilson, I.A. & Teyton, L. Crystal structures of mouse CD1d-iGb3 complex and its cognate Vα14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids. J. Mol. Biol. 377, 1104-1116 (2008).
28. Mallevaey, T. et al. T cell receptor CDR2β and CDR3β loops collaborate functionally to shape the iNKT cell repertoire. Immunity 31, 60-71 (2009).
29. Mallevaey, T. et al. A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 34, 315-326 (2011).
30. Wei, D.G., Curran, S.A., Savage, P.B., Teyton, L. & Bendelac, A. Mechanisms imposing the Vβ bias of Vα14 natural killer T cells and consequences for microbial glycolipid recognition. J. Exp. Med. 203, 1197-1207 (2006). (Pubitemid 43736590)
31. Christiansen, D. et al. Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation. PLoS Biol. 6, e172 (2008).
32. Porubsky, S. et al. Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. USA 104, 5977-5982 (2007). (Pubitemid 47175644)
33. Gapin, L. iNKT cell autoreactivity: what is 'self' and how is it recognized? Nat. Rev. Immunol. 10, 272-277 (2010).
34. Speak, A.O. et al. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Proc. Natl. Acad. Sci. USA 104, 5971-5976 (2007). (Pubitemid 47175643)
35. Schümann, J., Mycko, M.P., Dellabona, P., Casorati, G. & Macdonald, H.R. Cutting edge: influence of the TCR Vβ domain on the selection of semi-invariant NKT cells by endogenous ligands. J. Immunol. 176, 2064-2068 (2006). (Pubitemid 43201651)
36. Brigl, M. et al. Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors. J. Immunol. 176, 3625-3634 (2006). (Pubitemid 43364010)
37. Xia, C. et al. Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells. J. Med. Chem. 50, 3489-3496 (2007). (Pubitemid 47195458)
38. Florence, W.C. et al. Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligands. EMBO J. 28, 3579-3590 (2009).
39. Colf, L.A. et al. How a single T cell receptor recognizes both self and foreign MHC. Cell 129, 135-146 (2007). (Pubitemid 46507586)
40. Macdonald, W.A. et al. T cell allorecognition via molecular mimicry. Immunity 31, 897-908 (2009).
41. Tynan, F.E. et al. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat. Immunol. 8, 268-276 (2007). (Pubitemid 46745376)
42. Yin, N. et al. Alpha anomers of iGb3 and Gb3 stimulate cytokine production by natural killer T cells. ACS Chem. Biol. 4, 191-197 (2009).
43. Rudd, P.M., Elliott, T., Cresswell, P., Wilson, I.A. & Dwek, R.A. Glycosylation and the immune system. Science 291, 2370-2376 (2001). (Pubitemid 32231792)
44. Petrescu, A.-J., Milac, A.-L., Petrescu, S.M., Dwek, R.A. & Wormald, M.R. Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding. Glycobiology 14, 103-114 (2004). (Pubitemid 38263095)
45. Scott-Browne, J.P. et al. Germline-encoded recognition of diverse glycolipids by NKT cells. Nat. Immunol. 8, 1105-1113 (2007). (Pubitemid 47423758)
46. Arden, B. et al. Mouse T-cell receptor variable gene segment families. Immunogenetics. 42, 455-500 (1995). (Pubitemid 26025063)
47. Leslie, A.G. The integration of macromolecular diffraction data. Acta Crystallogr. D Biol. Crystallogr. 62, 48-57 (2006).
48. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126-2132 (2004). (Pubitemid 41742764)
49. Zwart, P.H. et al. Automated structure solution with the PHENIX suite. Methods Mol. Biol. 426, 419-435 (2008).
50. CCP4 (Collaborative Computational Project, 4). The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760-763 (1994).